Role of adenosine in isoflurane-induced cardioprotection

Anesthesiology

Volumn 86, Issue 5, 1997, Pages 1128-1139

  Kersten, Judy R ^a,c   Orth, Karl G ^a   Pagel, Paul S ^a   Mei, David A ^a   Gross, Garrett J ^a   Warltier, David C ^a,b  

^a Department of Anesthesiology ^*

^b Pharmacology and Toxicology

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adenosine 5'triphospate regulated potassium channels; Adenosine, antagonists: DPCPX; Anesthetics, volatile: isoflurane; Heart, myocardial stunning

Indexed keywords

ADENOSINE; ISOFLURANE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL MIGRATION; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG MECHANISM; HEART INFARCTION; HEART PROTECTION; HEMODYNAMIC MONITORING; INHALATIONAL DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; REPERFUSION;

EID: 0031005282     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199705000-00017     Document Type: Article

References (41)

1. Nicklas JM, Becker LC, Bulkley BH: Effects of repeated brief coronary occlusion on regional left ventricular function and dimension in dogs. Am J Cardiol 1985; 56:473-8
2. Dorheim TA, Huffman A, Van Wylen DG, Mentzer RM Jr: Enhanced interstitial fluid adenosinc attenuates myocardial stunning. Surgery 1991; 110:136-45
3. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, Bolli R: Effect of adenosine on myocardial "stunning" in the dog. Circ Res 1995; 76:82-94
4. Yao Z, Gross GJ: Glibenclamide antagonizes adenosine AI receptor-mediated cardioprotection in stunned canine myocardium. Circulation 1993; 88:235-44
5. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, Sun JZ, Sekili S, Tang XL, Bolli R: Augmentation of endogenous adenosine attenuates myocardial "stunning" independently of coronary flow or hemodynamic effects. Circulation 1993; 88:2359-69
6. Roberts PA, Newby AC, Hallet MB, Campbell AK: Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leucocytes. Biochem J 1985; 227:669-74
7. Ely SW, Mentzer RM Jr, Lasley RD, Lee BK, Berne RM: Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 1985; 90:549-56
8. Mauser M, Hoffmeister HM, Nienaber C, Schaper W: Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary arter occlusion in the dog. Circ Res 1985; 56:222-30
9. Belardinelli L, Linden J, Berne RM: The cardiac effects of adenosine. Prog Cardivasc Dis 1989; 32:73-97
10. Wyatt DA, Edmunds MC, Rubio R, Berne RM, Lasley RD, Mentzer RM Jr: Adenosine stimulates glycolytic flux in isolated perfused rat hearts by Al-adenosine receptors. Am J Physiol 1989; 257:H1952-7
11. 2+ current inhibition. Surgery 1993; 114:334-42
12. Randhawa MP Jr, Lasley RD, Mentzer RM Jr: Adenosine and the stunned heart. J Card Surg 1993; 8:332-7
13. Richardt G, Waas W, Kranzhofer R, Mayer E, Schomig A: Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: A protective mechanism in early myocardial ischemia. Circ Res 1987; 61:117-23
14. Dobson JG Jr: Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3′,5′-monophosphate formation and gylcogen phosphorylase activity in rat heart muscle. Circ Res 1978; 43:785-92
15. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 1990; 259:11820-6
16. Warltier DC, Al-Wathiqui MH, Kampine JP, Schmeling WT: Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. ANESTHESIOLOGY 1988; 69:552-65
17. ATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 1996; 83:27-33
18. ATP) channels. ANESTHESIOLOGY 1996; 85:794-807
19. Van Wylen DG: Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994; 89:2283-9
20. Rooke GA, Feigl EO: Work as a correlate of canine left ventricular oxygen consumption, and the problem of catccholamine oxygen wasting. Circ Res 1982; 50:273-86
21. Van Wylen DG, Willis J, Sodhi J, Weiss RJ, Lasley RD, Mentzer RM Jr: Cardiac microdialysis to estimate interstitial adenosine and coronary blood How. Am J Physiol 1990; 258:111642-9
22. Mei DA, Gross GJ, Nithipatikom K: Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high performance liquid Chromatography with a diode array detector. Anal Biochem 1996; 238:34-9
23. 1-receptors. Circulation 1992; 86:1310-6
24. ATP channels and ischemic preconditioning in dogs. Am J Physiol 1993; 264:H1327-36
25. Gross GJ, Yao Z, Auchampach JA: Chapter 7: Role of ATP-sensitive potassium channels in ischemic preconditioning, Ischemic Preconditioning: The Concept of Endogenous Cardioprotection. Edited by Przyklenk K, Kloner RA, Yellon DM. Boston, Kluwer Academic Publishers, 1995, pp 125-35
26. + currents by protein kinase C and adenosine: Implications for ischemic preconditioning. Circ Res 1996; 78:443-54
27. Auchampach JA, Maruyama M, Cavero I, Gross GJ: Pharmacological evidence for a role of ATP-regulated potassium channels in myocardial stunning. Circulation 1992; 86:311-9
28. + channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther 1991; 259:961-7
29. Gross GJ, Auchampach JA: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70:223-33
30. Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG: Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989; 251:98-104
31. Lohse MJ, Klotz KM, Lindenborn-Fotinos J, Reddington M, Schwabe U, Olsson RA: 8-Cyclopentyl-1,3-dipropylxanthine (DPCPS) - A selective high affinity antagonist radioligand for Al adenosine receptors. Naunyn-Sclimiedebergs Arch Pharmacol 1987; 336:204-10
32. + channels in cardiac muscle. Nature 1983; 305:147-8
33. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991; 69:571-81
34. McPherson CD, Pierce GN, Cole WC: Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation. Am J Physiol 1993; 265:111809-18
35. Abd-Elfattah A-S, Guo J-H, El-Guessab E-M, Wechsler AS: Physiologic and pathophysiologic significance of purine metabolism in the heart, Purines and Myocardial Protection. Edited by Abd-Elfattah A-S, Wechsler AS. Boston, Kluwer Academic Publishers, 1996, pp 3-16
36. Reimer KA, Vander Heide RS, Murry CE, Jennings RB: Chapter 5: Role of altered energy metabolism in ischemic preconditioning, Ischemic Preconditioning: The Concepts of Endogenous Cardioprotection. Edited by Przyklenk K, Kloner RA, Yellon DM. Boston, Kluwer Academic Publishers, 1994, pp 75-103
37. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM: Protection against infarction afforded by preconditioning is mediated by Al adenosine receptors in rabbit heart. Circulation 1991; 84:350-6
38. Mizumura T, Nithipatikom K, Gross GJ: Bimikalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995; 92:1236-45
39. Kanaya N, Fujita S: The effects of isollurane on regional myocardial contractility and metabolism in "stunned" myocardium in acutely instrumented dogs. Anesth Analg 1994; 79:447-54
40. Kanaya N, Kobayashi I, Nakayama M, Fujita S, Namiki A: ATP sparing effect of isoflurane during ischaemia and reperfusion of the canine heart. Br J Anaesth 1995; 74:563-8
41. Cason BA, Shubayev I, Hickey RF: Blockade of adenosine triphospliate-sensitive potassium channels eliminates isoflurane-induccd coronary artery vasodilation. ANESTHESIOLOGY 1994; 81:1245-55